Genesys International board to consider ESOP scheme on September 2, 2026
- Genesys International Corporation has scheduled a board meeting for Wednesday, September 2, 2026
- The primary agenda item is the consideration and approval of the Genesys Employee Stock Option Scheme - 2026
- The scheme is subject to shareholder approval before implementation
- The intimation was issued on August 28, 2026, pursuant to Regulation 29 of the SEBI (LODR) Regulations, 2015

*this image is generated using AI for illustrative purposes only.
Genesys International Corporation has scheduled a board meeting on Wednesday, September 2, 2026, to consider the Genesys Employee Stock Option Scheme - 2026.
Board meeting agenda
The meeting has been convened under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation was issued on August 28, 2026, by the Company Secretary and Compliance Officer.
The following matters are listed for consideration at the meeting:
- Genesys Employee Stock Option Scheme - 2026, subject to approval of the shareholders of the company
- Any other matter as may arise
Key meeting details
The table below summarises the key details of the scheduled board meeting:
| Parameter | Details |
|---|---|
| Meeting date | Wednesday, September 2, 2026 |
| Regulatory basis | Regulation 29, SEBI (LODR) Regulations, 2015 |
| Primary agenda item | Genesys Employee Stock Option Scheme - 2026 |
| Subject to | Shareholder approval |
| Intimation date | August 28, 2026 |
The proposed Employee Stock Option Scheme - 2026 will require shareholder approval before it can be implemented, as stated in the board meeting notice.
Historical Stock Returns for Genesys International Corp
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.86% | +24.11% | +11.13% | +11.09% | -42.20% | +151.41% |
What specific vesting schedules and exercise prices are proposed in the Genesys Employee Stock Option Scheme - 2026?
How might the dilution from this new ESOP impact Genesys International's earnings per share (EPS) and existing shareholder equity?
Which key executives or employee groups are expected to be the primary beneficiaries of the 2026 ESOP scheme?


































